Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fesoterodine with tolterodine ER in patients with overactive bladder has completed and results have been posted. The study evaluated eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Detrol LA (tolterodine tartrate)
• Toviaz (fesoterodine fumarate)

Snippet

Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED | Results posted: 2011-01-12